Skip to Search
Skip to Navigation
Skip to Content
Skip to Search
Skip to Navigation
Skip to Content
photo26.jpgphoto29.jpgphoto17.jpgphoto23.jpg
Faculty and Staff

Michael M. Copenhaver, Ph.D.
Department of Allied Health Sciences, U-1101
358 Mansfield Road
University of Connecticut
Storrs, CT 06269-1101
Phone: (860) 486-2846
Fax: (860) 486-0533
Email: michael.copenhaver@uconn.edu

Education

Yale University School of Medicine, New Haven, CT (2000). Post-doctoral training in clinical psychology in the Department of Psychiatry, Division of Substance Abuse.

Yale University School of Medicine, New Haven, CT (1999). Clinical psychology internship training in the Department of Psychiatry, Division of Substance Abuse.

Virginia Tech, Blacksburg, VA (1994-1999). Doctoral training in clinical psychology (Ph.D.) in the Department of Psychology. Dissertation title: Testing a social-cognitive model of intimate abusiveness among substance dependent males.

Villanova University, Villanova, PA (1987-1989). Master of Science in experimental psychology (M.S.) in the Department of Psychology. Thesis title: The Effect of Spatial Contrast Sensitivity on Pseudo-isochromatic Test Performance.

Clemson University, Clemson, SC (1983-1987). Bachelor of Art in Psychology (B.A.) in the Department of Psychology.

Professional Experience

Associate Professor
2010-present (Assistant Prof. 2007-2010)
Department of Allied Health Sciences, joint appointment with Department of Psychology, University of Connecticut, Storrs, CT. 60/40 (Research/Teaching) tenure track academic appointment.

Teach a yearly graduate course on Interventions for At-risk Populations (GPAH 5319) which is a core graduate course for the Allied Health Sciences graduate program in Health Promotion and is also designed to fulfill licensure requirements for doctoral students in Clinical Psychology.

Teach an undergraduate course each semester on Research Methods (AHS 4241W) which is a core course for all Allied Health Sciences majors and involves separate lecture and discussion modalities of instruction.

Assistant Research Professor
2002-2007
Department of Psychology, Center for Health, Intervention, & Prevention (CHIP), University of Connecticut, Storrs, CT

As PI, responsible for designing and conducting federally-funded behavioral HIV prevention research. Developed and taught a graduate course in clinical psychology, Integrative Treatment with Special Populations (Psych. 317) which is an intensive clinical course on assessment and treatment with challenging cases including substance abuse, domestic violence, child maltreament, and sexual dysfunctions.

Associate Research Scientist (Licensed Clinical Psychologist)
1999-2002
Department of Psychiatry, Yale University School of Medicine, New Haven, CT Clinical Psychology Fellow
1998–1999
Department of Psychiatry, Yale University School of Medicine, New Haven, CT Graduate Instructor
1994-1998
Department of Psychology, Virginia Tech, Blacksburg, VA

Taught Research Methods, Psychology Research Methods, Social Psychology, Personality Assessment, Cognitive Psychology labs, and Introductory Psychology labs

Research Associate
1989-1994
CAE Link Corporation, Fairfax, VA

Memberships and Other Activities

Memberships

American Psychological Association Member (since 1994)

College on Problems of Drug Dependence (since 2003)

Committees

2010–present, Chairperson, CANR Excellence Committee, University of Connecticut

National Institutes of Health, Center for Scientific Review, Review Panel Member, RFA-DA-11-001 (2/11)

National Institutes of Health, Center for Scientific Review, Review Panel Member, ZDA1 LXF-L-01 (3/11)

2009-present, Editorial Board, AIDS & Behavior

National Institutes of Health, Center for Scientific Review, SBIR Phase I & II Review Panel Member (2/10; 3/10; 5/10)

National Institutes of Health, Center for Scientific Review; Review Panel Member, ARRA RC4 Sustainable Community-linked Infrastructure (2/10)

National Institutes of Health, Center for Scientific Review, ZRG1 AARR-F(52) Review Panel member (12/09)

Chairperson, Centers for Disease Control and Prevention Special Emphasis Panel (CD09-001 Panel F; 2009)

Research Scientist Appointment Committee member (2009-present), Center for Health, Intervention, & Prevention (CHIP), University of Connecticut.

National Institutes of Health, Center for Scientific Review, ZDA1 LXF-L (SEP) Review Panel member (03/09)

Centers for Disease Control and Prevention PS09-002 (SEP) Review Panel member (03/09)

Chairperson, Internal Grant Review Committee (2008-present), Center for Health, Intervention, & Prevention (CHIP), University of Connecticut.

Centers for Disease Control and Prevention, Peer Review Meeting for PAR07-231 (7/08)

National Institutes of Health, Center for Scientific Review, ZDA1 MXS-M (CJDATS2) Review Panel member (11/08)

Graduate Program in the Department of Allied Health Science Committee member (2007-present), University of Connecticut.

Research Scientist Appointment Committee member (2009-present), Center for Health, Intervention, & Prevention (CHIP), University of Connecticut.

Executive Committee member (2007-present), Center for Health, Intervention, & Prevention (CHIP), University of Connecticut.

Centers for Disease Control and Prevention, Peer Review Meeting for RFA PS07-003 SEP (5/07).

Centers for Disease Control and Prevention, Peer Review Meeting for RFA PS07-004 SEP (5/07)

National Institutes of Health, Center for Scientific Review, ZRG1 AARR-F (02) SEP Review Group Member (11/05)

Graduate Student Grant Review Panel member (2003- present), Center for Health, Intervention, & Prevention (CHIP), University of Connecticut.

National Institutes of Health, Center for Scientific Review, ZRG1 AARR-F (01) SEP Review Group Member (12/04)

Judicial Hearing Board member (2003-present), University of Connecticut

Ad Hoc Review Committee member for

Journal of AIDS, Journal of Consulting and Clinical Psychology, Drug and Alcohol Dependence, Journal of Substance Abuse Treatment, Addiction, AIDS Care, Journal of Urban Health, AIDS & Behavior, Psychological Assessment, Health Psychology, AIDS Patient Care & STDs.

Publications

Peer-reviewed full-length publications

Copenhaver, M., Tunku, N., Ezeabogu, I., Potrepka, J., Zahari, M., Kamarulzaman, A., & Altice, F. (in press 2011). Adapting an Evidence-based Intervention Targeting HIV-infected Prisoners in Malaysia. AIDS Research & Treatment.

Ezeabogu, I., Copenhaver, M., & Potrepka, J. (in press 2011). The Influence of Neurocognitive Impairment on Treatment Outcomes among Drug-involved People Living with HIV/AIDS. AIDS Care.

Copenhaver, M., Lee, I.C , Margolin, A., Bruce, R., & Altice, F. (2011). Testing an Optimized Community-Based Human Immunodeficiency Virus (HIV) Risk Reduction and Antiretroviral Adherence Intervention for HIV-Infected Injection Drug Users, Substance Abuse, 32(1), 16-26.

Copenhaver, M., Lee, I.C., Merz-Beyus, A. & Faghri, P. (2010). The Living Arrangement May Differentially Influence IDU Parents’ Motivation to Reduce HIV risk as a Function of Gender. AIDS Care, 22(11), 1373-1378.

Anand, P., Springer, S., Copenhaver, M., & Altice, F. (2010). Neurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship. AIDS & Behavior, 14, 1213-26.

Copenhaver, M., Chowdhury, S., & Altice, F. (2009). Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: The process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention. AIDS Patient Care & STDs, 23(3), 1-11.

Norton, W., Amico, R., Fisher, W., Copenhaver, M., Cornman, D., Friedland, G., Kozal, M., & Fisher, J. (2008). IDU risk behavior and attitudinal correlates in a sample of HIV-infected patients in clinical care. AIDS Care, 20 (4), 462-469.

Copenhaver, M., Bruce, R., & Altice, F. (2007). Behavioral Counseling Content for Optimizing the Use of Buprenorphine for Opioid Dependence in Community Based Settings: A Review of the Empirical Evidence. American Journal of Drug and Alcohol Abuse, 33, 1-12.

Copenhaver, M., & Lee, I. (2007). Examining the decay of HIV risk reduction outcomes following a community-friendly intervention targeting injection drug users in treatment. Journal of Psychoactive Drugs,39(3), 223-229.

Copenhaver, M., Lee, I., & Margolin, A. (2007). Successfully integrating HIV risk reduction into a community-based treatment program. American Journal of Drug and Alcohol Abuse, 33(1), 109-120.

Copenhaver, M. & Lee, I. (2006). Optimizing a Community-friendly HIV Risk Reduction Intervention for Injection Drug Users in Treatment: A Structural Equation Modeling (SEM) Approach. Journal of Urban Health, 83(6), 1132-1142.

Copenhaver, M., Johnson, B.T., Lee, I., Carey, M., & Harman, J. (2006). Behavioral HIV risk reduction among injection drug users: Meta-analytic evidence of efficacy. Journal of Substance Abuse Treatment, (31), 163-171.

Copenhaver, M., & Fisher, J. (2006). Experts outline ways to improve the decade-long U.S. trend of 40,000 new HIV infections per year. AIDS & Behavior, 10(1), 105-114. Copenhaver, M., Margolin, A., Avants, K., & Warburton, L. (2003). Intervening effectively with drug abusers infected with HIV: Taking into account the potential for cognitive impairment. Journal of Psychoactive Drugs, 35(2), 209-218.

Margolin, A., Kantak, K., Copenhaver, M.M., Avants, K.(2003). A preliminary controlled investigation of magnesium L-aspartate hydrocholoride for illicit cocaine and opiate use in methadone-maintained patients. Journal of Addictive Diseases, 22(2), 49-62.

Copenhaver, M.M. (2000). Testing a social-cognitive model of intimate abusiveness among substance dependent males. American Journal of Drug and Alcohol Abuse, 26(4), 603-628.

Copenhaver, M.M., Lash, S. J., & Eisler, R.M., (2000). Masculine Gender-Role Stress, Anger, and Male Intimate Abusiveness: Implications for Men's Relationships. Sex Roles: A Journal of Research, 42 (5/6), 405-414.

Copenhaver, M.M., & Eisler, R.M. (2000). The Development and Validation of the Feelings Toward Father Scale (FTFS): A Tool for Assessing the Father's Role in Children's Psychopathologies. Behavior Modification, 24(5), 740-750.

Lash, S.J., & Copenhaver, M.M. (1998). Masculine Gender-Role Stress and Substance Abuse Among Substance Dependent Males. Journal of Gender, Culture, and Health, 3(3), 183-191.

Copenhaver, M.M. (1996). The Role of Fathers in Their Children's Psychological Development: Implications for the Prevention of Psychopathologies. Journal of Gender, Culture, and Health, 1(3), 221-246.

Published reviews and book chapters

Copenhaver, M. (2005). Book review for Treisman and Angelino: “The psychiatry of AIDS, A guide to diagnosis and treatment”. Baltimore, MD: Johns Hopkins University Press.

Copenhaver, M.M., & Eisler, R.M. (1996). Masculine gender role stress: A perspective on men's health. In In P.M. Kato (Ed.), Health psychology of special populations: Issues in age, gender, and ethnicity. New York: Plenum.

Research Grant Activities

Ongoing Federally-funded Research Grants

R01DA025943. Copenhaver (Co-I). 9/30/2008 – 06/30/2013
National Institutes of Health, National Institute on Drug Abuse
Title: Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia
Role: Co-I (Altice PI)
Funds Received: $125,736 (includes only my salary support)

U01 DA025282. Copenhaver (Co-I). 9/1/2008 – 8/31/2013
National Institutes of Health, National Institute on Drug Abuse
Title: Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2)
Role: Co-I
Funds Received: $138,000 (includes only my salary support)

2008-R-26-CDC. Copenhaver (Co-I). 9/1/2008 – 8/31/2010
Centers for Disease Control and Prevention
Title: Incentivized Worksite Weight Loss Program in the Nursing Home Sector
Role: Co-I
Funds received: n/a (in kind support)

R01 DA022122. Copenhaver (PI). 9/30/2006 – 11/30/2011
National Institutes of Health, National Institute on Drug Abuse
Title: Testing a Community-Friendly Risk Reduction Intervention for Drug Users
Role: PI
Funds Received: $2,400,137

Completed Federally-funded Research

R21 DA021093. Copenhaver (PI). 9/30/2006 – 6/30/2009
National Institutes of Health, National Institute on Drug Abuse
Title: A Healthy Transition for Newly Released HIV-infected Prisoners
Role: PI
Funds Received: $275,000

K23 DA17015. Copenhaver (PI). 9/30/03 - 7/1/08
National Institutes of Health, National Institute on Drug Abuse
Title: Optimizing HIV prevention for HIV-positive Injection Drug Users
Role: PI
Funds Received: $555,304

Completed State-funded Research

DPH #H02-436. Copenhaver (PI). 7/1/02 – 6/30/05
Department of Public Health, AIDS Division, State of Connecticut
Title: Harm Reduction Group Level HIV Prevention Intervention for Injection Drug Users.
Role: PI

Invited Presentations

Ezeabogu, I., & Copenhaver, M. (2010). The influence of neuro-cognitive impairment on intervention outcomes among injection drug users living with HIV/AIDS. Presentation at the annual conference of the College on Problems of Drug Dependence (CPDD). Scottsdale, AZ.

Potrepka, J., & Copenhaver, M. (2010). The impact of age of drug use debut on subsequent HIV risk behavior among injection drug users. Presentation at the annual conference of the College on Problems of Drug Dependence (CPDD). Scottsdale, AZ.

Copenhaver, M. (October, 2009). Guest speaker (for Dr. Pouran Faghri, AHS), ‘Changing and evaluating motivation to reduce HIV risk among drug users in treatment’. Storrs, CT.

Copenhaver, M. (November, 2009). Guest speaker (for Dr. Fridell, AHS), ‘Adapting behavioral interventions to address health risk behaviors among priority populations.’ Storrs, CT.

Copenhaver, M., Evans, L., Sylla, L., Boticello, P., MacGowan, R., & Altice, F. (August, 2009). Positive Living Using Safety (PLUS): Evaluation of an HIV risk reduction intervention for HIV-infected prisoners. Presentation at the National Conference on HIV Prevention (NCHP) annual conference. Atlanta, GA.

Copenhaver, M., Merz, A. (g), & Lee, I.C. (June, 2008). Children as Motivation to Reduce HIV Risk: Gender Differences Between IDU Parents in Treatment. Presentation at the College on Problems of Drug Dependence (CPDD) annual conference. San Juan, Puerto Rico.

Amaechi, O. (g), Lee, I.C., & Copenhaver, M. (June, 2008). A Brief Behavioral Intervention to Enhance Medication Adherence Among HIV-infected Injection Drug Users. Presentation at the College on Problems of Drug Dependence (CPDD) annual conference. San Juan, Puerto Rico.

Bruce, R.D., Acosta, A. (g), Copenhaver, M, & Altice, F.L. (June, 2008). Hepatitis C Treatment Among Methadone-Maintained Patients: Directly-Observed Therapy Compared with Standard-of-Care. Presentation at the College on Problems of Drug Dependence (CPDD) annual conference. San Juan, Puerto Rico.

Copenhaver, M. (October, 2007). Guest speaker (for Dr. Pouran Faghri), ‘Optimizing HIV risk reduction using Multiple Levels of Analysis’. Storrs, CT.

Copenhaver, M. (October, 2007). Guest speaker (for Dr. Valerie Duffy), ‘Changing HIV Risk Behavior Among Injection Drug Users: A Harm Reduction Model’. Storrs, CT.

Copenhaver, M. (November, 2007). Allied Health Sciences colloquium, ‘Reducing HIV Risk Behavior Among IDUs: Philosophy, Ingredients, & Implementation’. Storrs, CT.

Copenhaver, M. (March, 2008). Guest speaker (for Maryann Morris), ‘Using Motivation to Reduce HIV Risk Behavior Among Drug Users’. Storrs, CT.

Copenhaver, M. (February, 2008). Guest speaker for graduate seminar course in health intervention research (for instructor Dr. Seth Kalichman), “Reducing HIV risk among HIV-infected prisoners”. Storrs, CT.

Copenhaver, M., Bruce, R., & Altice, F. (June, 2007). The feasibility of delivering a brief HIV risk reduction intervention targeting HIV-infected IDUs in a community-based setting. Presentation at the annual conference of the College on Problems of Drug Dependence (CPDD). Quebec City, Canada.

Altice, F., Copenhaver, M., & Bruce, R. (June, 2007). A review of behavioral counseling content for optimizing the use of buprenorphine for treating opioid-dependence in U.S. drug-treatment CBOs. Presentation at the annual conference of the College on Problems of Drug Dependence (CPDD). Quebec City, Canada.

Copenhaver, M. (October, 2006). Moving toward an optimized HIV risk reduction Intervention targeting drug users. Invited presentation at the Center for Health, Intervention, & Prevention’s lecture series. Storrs, CT.

Lee, I.C. & Copenhaver, M. (June, 2006). Refining an HIV risk reduction intervention using a structural equations modeling (SEM) approach. Presentation at the annual conference of the College on Problems of Drug Dependence (CPDD). Scottsdale, AZ.

Copenhaver, M. & Lee, I.C. (June, 2006). Examining the potency of a community-friendly HIV risk reduction intervention. Presentation at the annual conference of the College on Problems of Drug Dependence (CPDD). Scottsdale, AZ.

Altice, F., Copenhaver, M., Bruce, R.A. (June, 2006). Integrating evidence-based counseling with routine buprenorphine treatment for opiate dependence. Presentation at the annual conference of the College on Problems of Drug Dependence (CPDD). Scottsdale, AZ.

Copenhaver, M., Lee, I.C., Harman, J., Johnson, B.T., & Carey, M. (August, 2005). Key components in behavioral HIV risk reduction interventions targeting injection drug users: A meta-analysis. Invited poster presentation given at the NIDA K-grant awardee conference. Bethesda, MD.

Lee, I.C. & Copenhaver, M. (2005). HIV risk reduction can be integrated into substance abuse treatment. Oral presentation (by Copenhaver) at the annual conference of the College on Problems of Drug Dependence (CPDD). Orlando, FL.

Copenhaver, M., Lee, I.C., Harman, J., Johnson, B.T., & Carey, M. (2005). Specifying the key components of HIV risk reduction interventions targeting IDUs. Poster presentation at the annual conference of the College on Problems of Drug Dependence (CPDD). Orlando, FL.

Fisher, J.D. & Copenhaver, M. (2005). Experts outline ways to improve the trend of 40,000 new infections per year in the U.S.. Poster presentation (by Copenhaver) at the annual conference of the College on Problems of Drug Dependence (CPDD). Orlando, FL.

Copenhaver, M. (2004, September). Invited panel member for NIH/NIDA, “Integrating HIV Prevention in Substance Abuse Treatments”. Bethesda, MD.

Copenhaver, M. (2004, March). Invited panel member for NIH/NIDA, “Phase IV Randomized, Controlled Study to Optimize the Concurrent Use of Buprenorphine & Highly Active Anti-Retroviral Therapy in HIV+ Opioid Dependent Persons”, Tampa, FL.

Copenhaver, M. (2003, October). Invited panel member for NIH/NIDA, “Integrating Treatment with Buprenorphine and HAART”, Rockville, MD.

Copenhaver, M. (2003, June). “Behavioral Interventions for Substance Abusers with Cognitive Impairment”. Invited presentation given as a panel member at the National Institutes of Health/National Institute on Drug Abuse (NIH/NIDA) meeting, Bethesda, MD.

Copenhaver, M. (2002, November). “HIV Harm Reduction Interventions for Substance Abusers: Taking into Account Cognitive Impairment”. Invited presentation given at the Social Division lecture series, University of Connecticut, Psychology Department, Storrs, CT.

Copenhaver, M. (2002). “Behavioral Treatment Interventions for HIV+ Methadone-Maintained Patients”. Invited symposium given at the American Society of Addiction Medicine conference, Atlanta, GA.

Copenhaver, M. & Warburton, L. (2001). “Holistic HIV Harm Reduction Intervention In-Service for Substance Abuse Counselors”. In-Service given at the APT Foundation Continuing Education for CADAC Certified Counselors, May 4, 2001.

Copenhaver, M., and Usubiaga, H. (2001). “HIV Harm Reduction Intervention In-Service for Substance Abuse Counselors”. In-Service given at Department of Psychiatry Psychotherapy Seminar Series.

Copenhaver, M., and Usubiaga, H. “Harm Reduction Approach to HIV-Prevention Interventions” (2002). In-Service given at Department of Psychiatry Seminar Series.

Copenhaver, M.M., Moore, T., & Rhatigan, D. (1999). Testing a social-cognitive model of male intimate abusiveness among substance-dependent males. Poster presented at the Association for the Advancement of Behavior Therapy.

Copenhaver, M.M., & Eisler, R.M. (1995). Development and validation of the attitudes toward Father Scale (ATFS). Poster presented at the Association for the Advancement of Behavior Therapy conference, Washington, DC.

Copenhaver, M.M., and Youngberg, R. (1993). Predictors of Suicide Intent: Hopeless as a Critical Measure. Paper presented at Western Pennsylvania Psychological Association conference, Pittsburgh, PA.

Copenhaver, M.M., Wright, J.E., Youngberg, R., and Beck, A.T. (1992). Predictors of Suicide Intent. Paper presented at American Psychological Association, Washington, DC.

Copenhaver, M.M. (1989). The Effect of Spatial Contrast Sensitivity on Pseudoisochromatic Test Performance. Thesis presented at Villanova University, Villanova, PA.

Copenhaver, M.M., and Dane, F.C. (1987). The Quantification of Reasonable Doubt. Paper presented at the Southeastern Psychological Association, Atlanta, GA.

about AHS
Laboratory technologists are essential members of the health care team.

 

Department of Allied Health Sciences
College of Agriculture, Health and Natural Resources
358 Mansfield Road, Unit 1101
Storrs, Connecticut 06269-1101
Telephone: (860) 486-2834
Fax: (860) 486-5375